eGFR decline

Biomarker

2 papers3 findings

  • Human trial1
  • Humans1

Interventions

3

Tirzepatide

downin humans1

1 study
  1. Tirzepatide decreases eGFR decline in humans (ETD 3.9 ml/min per 1.73m2, p<0.001).

    “A significantly smaller decline in eGFR was observed with pooled TZP (-1.6±0.5 ml/min per 1.73m2) compared to placebo (-5.5±1.0 ml/min per 1.73m2) after 176 weeks”

    Human trialin participants with obesity or overweight and prediabetes176 weeks

    Association of Tirzepatide with Kidney Parameters in People with Obesity and Prediabetes from SURMOUNT-1 over 176 Weeks

    ADA Scientific Sessions 2025 abstract13 Jun 2025

More on Tirzepatide

Dietary animal protein

no changein humans1

1 study
  1. Dietary animal protein has no effect on eGFR decline in humans (P = 0.84).

    “The intake of animal protein was not associated with eGFR decline (P = 0.84).”

    Humans10 yearsfemalesn = 1,374

    Dietary plant and animal protein intake and decline in estimated glomerular filtration rate among elderly women: a 10-year longitudinal cohort study

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association27 Aug 2021

More on Dietary animal protein

Dietary plant protein

downin humans1

1 study
  1. Dietary plant protein decreases eGFR decline in humans (reduced by 0.12 mL/min/1.73 m2 per 10 g (95% CI 0.01-0.23)).

    “For each 10 g of plant protein, the yearly decline in eGFR was reduced by 0.12 mL/min/1.73 m2 (95% CI 0.01-0.23)”

    Humans10 yearsfemalesn = 1,374

    Dietary plant and animal protein intake and decline in estimated glomerular filtration rate among elderly women: a 10-year longitudinal cohort study

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association27 Aug 2021

More on Dietary plant protein

Funding

1 grant since 2026

National Institute of Diabetes and Digestive and Kidney DiseasesUS$133.9k

Latest

Nov 2025: 1Dec 2025: 0Jan 2026: 0Feb 2026: 1Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 6Jul 2026: 2Aug 2026: 6Sep 2026: 10Oct 2026: 632 in 12 months
The American Journal of Cardiology

Drug class linked to fewer deaths or complications in kidney disease

The two-year combined outcome rate was 15.6% for sodium-glucose cotransporter 2 inhibitors versus 19.9% for renin-angiotensin system inhibitors, the comparison drug…The two-year combined outcome rate was 15.6% for sodium-glucose cotransporter 2 inhibitors versus 19.9% for renin-angiotensin system inhibitors, the comparison drug class.

Cohort study in peopleKidney
Internal and Emergency Medicine

Disease patterns linked to kidney decline in older patients

In geriatric wards, a heart, lung and kidney disease pattern was associated with 2.24 times the odds of decline versus two other disease patterns.In geriatric wards, a heart, lung and kidney disease pattern was associated with 2.24 times the odds of decline versus two other disease patterns.

Cohort study of 6,755 peopleKidney
Kidney & Blood Pressure Research

Fractional uric acid excretion linked to kidney function decline

Higher fractional uric acid excretion was associated with eGFR decline after adjustment for confounders (odds ratio 1.218, 95% CI 1.176–1.262).Higher fractional uric acid excretion was associated with eGFR decline after adjustment for confounders (odds ratio 1.218, 95% CI 1.176–1.262).

Cross-sectional study in peopleKidney